Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette, +140

The Lancet Oncology

Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer +9

Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer

Astrid Guyot d’Asnières de Salins, Gaëlle Tachon, Romain Cohen, +15

ESMO Open

Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study

David Tougeron, Benjamin Sueur, Aziz Zaanan, +21

International Journal of Cancer

Cancer EpidemiologyGastrointestinal OncologyMedicineDmmr/msi Mcrc PatientsColorectal Cancer +12

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor

Louis de Mestier, Thomas Walter, Camille Evrard, +8

Neuroendocrinology

Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses

Louis de Mestier, Thomas Walter, Hédia Brixi, +11

Neuroendocrinology

Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge

Audelaure Junca, Gaëlle Tachon, Camille Evrard, +4

Cancers

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)

Mathias Brügel, Léa Letrillart, Camille Evrard, +26

European Journal of Cancer

Pancreatic CancerMedicineCovid-19 PandemicClinical EpidemiologyCovid-19 Epidemiology +6

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers

Camille Evrard, Stéphane Messina, David Sefrioui, +19

International Journal of Molecular Sciences

ImmunologyImmunoeditingPathologyImmunotherapyTumor Biology +15

Targeted RNA‐sequencing assays: a step forward compared to FISH and IHC techniques?

Gaëlle Tachon, Ulrich Cortes, Sophie Richard, +5

Cancer Medicine

PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer

Camille Evrard, Christophe Louvet, Farid El Hajbi, +18

Digestive and Liver Disease

Prodige 59-Durigast TrialGastrointestinal OncologyMedicineAdvanced Gastric CancerGastroenterology +7